Selected research
Industry Growth & Trends
Global Androgenic Alopecia Therapeutics Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Androgenic Alopecia Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Androgenic Alopecia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Androgenic Alopecia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Androgenic Alopecia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Androgenic Alopecia Therapeutics market include Aclaris Therapeutics, Almirall, Astellas Pharma, BiologicsMD, Brickell Biotech, Cipla, Concert Pharmaceuticals, Reddy's Laboratories and RiverTown Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Androgenic Alopecia Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Androgenic Alopecia Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Androgenic Alopecia Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Androgenic Alopecia Therapeutics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Androgenic Alopecia Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Androgenic Alopecia Therapeutics Market by Company
Aclaris Therapeutics
Almirall
Astellas Pharma
BiologicsMD
Brickell Biotech
Cipla
Concert Pharmaceuticals
Reddy's Laboratories
RiverTown Therapeutics
GlaxoSmithKline
Merck
Johnson & Johnson
Sun Pharma
Androgenic Alopecia Therapeutics Segment by Type
Medicine
Surgery
Other
Androgenic Alopecia Therapeutics Segment by Application
Hospital
Clinic
Other
Androgenic Alopecia Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgenic Alopecia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Androgenic Alopecia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgenic Alopecia Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Androgenic Alopecia Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Medicine
- Surgery
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Aclaris Therapeutics
- Almirall
- Astellas Pharma
- BiologicsMD
- Brickell Biotech
- Cipla
- Concert Pharmaceuticals
- Reddy's Laboratories
- RiverTown Therapeutics
- GlaxoSmithKline
- Merck
- Johnson & Johnson
- Sun Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Androgenic Alopecia Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Androgenic Alopecia Therapeutics Market Size by Region (2021-2032)
- 1.4.1 Global Androgenic Alopecia Therapeutics Market Size by Region (2021-2026)
- 1.4.2 Global Androgenic Alopecia Therapeutics Market Size by Region (2027-2032)
- 1.5 Key Regions Androgenic Alopecia Therapeutics Market Size (2021-2032)
- 1.5.1 North America Androgenic Alopecia Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Androgenic Alopecia Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Androgenic Alopecia Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Androgenic Alopecia Therapeutics Market Size Growth Rate (2021-2032)
2 Androgenic Alopecia Therapeutics Market by Type
- 2.1 Type Introduction
- 2.1.1 Medicine
- 2.1.2 Surgery
- 2.1.3 Other
- 2.2 Global Androgenic Alopecia Therapeutics Market Size by Type
- 2.2.1 Global Androgenic Alopecia Therapeutics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Androgenic Alopecia Therapeutics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Androgenic Alopecia Therapeutics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Androgenic Alopecia Therapeutics Market Size by Regions
- 2.3.1 North America Androgenic Alopecia Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Androgenic Alopecia Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Androgenic Alopecia Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Androgenic Alopecia Therapeutics Market Size Breakdown by Type (2021-2026)
3 Androgenic Alopecia Therapeutics Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Other
- 3.2 Global Androgenic Alopecia Therapeutics Market Size by Application
- 3.2.1 Global Androgenic Alopecia Therapeutics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Androgenic Alopecia Therapeutics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Androgenic Alopecia Therapeutics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Androgenic Alopecia Therapeutics Market Size by Regions
- 3.3.1 North America Androgenic Alopecia Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Androgenic Alopecia Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Androgenic Alopecia Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Androgenic Alopecia Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Androgenic Alopecia Therapeutics Industry Trends
- 4.2 Androgenic Alopecia Therapeutics Industry Drivers
- 4.3 Androgenic Alopecia Therapeutics Industry Opportunities and Challenges
- 4.4 Androgenic Alopecia Therapeutics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Androgenic Alopecia Therapeutics Revenue (2021-2026)
- 5.2 Global Androgenic Alopecia Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Androgenic Alopecia Therapeutics Key Company Headquarters & Area Served
- 5.4 Global Androgenic Alopecia Therapeutics Company, Product Type & Application
- 5.5 Global Androgenic Alopecia Therapeutics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Androgenic Alopecia Therapeutics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Androgenic Alopecia Therapeutics Players Market Share by Revenue in 2025
- 5.6.3 2025 Androgenic Alopecia Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Aclaris Therapeutics
- 6.1.1 Aclaris Therapeutics Company Information
- 6.1.2 Aclaris Therapeutics Business Overview
- 6.1.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Aclaris Therapeutics Androgenic Alopecia Therapeutics Product Portfolio
- 6.1.5 Aclaris Therapeutics Recent Developments
- 6.2 Almirall
- 6.2.1 Almirall Company Information
- 6.2.2 Almirall Business Overview
- 6.2.3 Almirall Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Almirall Androgenic Alopecia Therapeutics Product Portfolio
- 6.2.5 Almirall Recent Developments
- 6.3 Astellas Pharma
- 6.3.1 Astellas Pharma Company Information
- 6.3.2 Astellas Pharma Business Overview
- 6.3.3 Astellas Pharma Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Astellas Pharma Androgenic Alopecia Therapeutics Product Portfolio
- 6.3.5 Astellas Pharma Recent Developments
- 6.4 BiologicsMD
- 6.4.1 BiologicsMD Company Information
- 6.4.2 BiologicsMD Business Overview
- 6.4.3 BiologicsMD Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 BiologicsMD Androgenic Alopecia Therapeutics Product Portfolio
- 6.4.5 BiologicsMD Recent Developments
- 6.5 Brickell Biotech
- 6.5.1 Brickell Biotech Company Information
- 6.5.2 Brickell Biotech Business Overview
- 6.5.3 Brickell Biotech Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Brickell Biotech Androgenic Alopecia Therapeutics Product Portfolio
- 6.5.5 Brickell Biotech Recent Developments
- 6.6 Cipla
- 6.6.1 Cipla Company Information
- 6.6.2 Cipla Business Overview
- 6.6.3 Cipla Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Cipla Androgenic Alopecia Therapeutics Product Portfolio
- 6.6.5 Cipla Recent Developments
- 6.7 Concert Pharmaceuticals
- 6.7.1 Concert Pharmaceuticals Company Information
- 6.7.2 Concert Pharmaceuticals Business Overview
- 6.7.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product Portfolio
- 6.7.5 Concert Pharmaceuticals Recent Developments
- 6.8 Reddy's Laboratories
- 6.8.1 Reddy's Laboratories Company Information
- 6.8.2 Reddy's Laboratories Business Overview
- 6.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Reddy's Laboratories Androgenic Alopecia Therapeutics Product Portfolio
- 6.8.5 Reddy's Laboratories Recent Developments
- 6.9 RiverTown Therapeutics
- 6.9.1 RiverTown Therapeutics Company Information
- 6.9.2 RiverTown Therapeutics Business Overview
- 6.9.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 RiverTown Therapeutics Androgenic Alopecia Therapeutics Product Portfolio
- 6.9.5 RiverTown Therapeutics Recent Developments
- 6.10 GlaxoSmithKline
- 6.10.1 GlaxoSmithKline Company Information
- 6.10.2 GlaxoSmithKline Business Overview
- 6.10.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 GlaxoSmithKline Androgenic Alopecia Therapeutics Product Portfolio
- 6.10.5 GlaxoSmithKline Recent Developments
- 6.11 Merck
- 6.11.1 Merck Company Information
- 6.11.2 Merck Business Overview
- 6.11.3 Merck Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Merck Androgenic Alopecia Therapeutics Product Portfolio
- 6.11.5 Merck Recent Developments
- 6.12 Johnson & Johnson
- 6.12.1 Johnson & Johnson Company Information
- 6.12.2 Johnson & Johnson Business Overview
- 6.12.3 Johnson & Johnson Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Johnson & Johnson Androgenic Alopecia Therapeutics Product Portfolio
- 6.12.5 Johnson & Johnson Recent Developments
- 6.13 Sun Pharma
- 6.13.1 Sun Pharma Company Information
- 6.13.2 Sun Pharma Business Overview
- 6.13.3 Sun Pharma Androgenic Alopecia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Sun Pharma Androgenic Alopecia Therapeutics Product Portfolio
- 6.13.5 Sun Pharma Recent Developments
7 North America
- 7.1 North America Androgenic Alopecia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 7.3 North America Androgenic Alopecia Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Androgenic Alopecia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 8.3 Europe Androgenic Alopecia Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Androgenic Alopecia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 10.3 South America Androgenic Alopecia Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst